ALEXANDER ANZARDO: Open Payments
NPI 1588013114 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 28 payments from 7 companies in 2025. Trend: 2023 $413 · 2024 $264 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 20 | $530 |
| Aroa Biosurgery Incorporated | 3 | $80 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| PFIZER INC. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Bioventus LLC | 1 | $19 |
Products named: EVOS, MAVERICK, Trigen, ELIQUIS, Exparel, GATTEX, EXOGEN ULTRASOUND BONE HEALING SYSTEM, LARGE CANNULATED SCREWS.
Industry payments across FL — which companies pay providers there.
